Afatinib and Selumetinib in Advanced KRAS Mutant and PIK3CA Wildtype Non-small Cell Lung Cancer
Clinical trial NCT02450656 · UNKNOWN
Trial details
- NCT number
- NCT02450656
- Sponsor
- The Netherlands Cancer Institute
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2019-05-01
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.